John DeNeen Collins, the CFO and COO of $LPSN ($LPSN), sold 130,000 shares of the company on 11-22-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 11.5% of their shares. Following this trade, they now own 997,604 shares of $LPSN stock.
$LPSN Insider Trading Activity
$LPSN insiders have traded $LPSN stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $LPSN stock by insiders over the last 6 months:
- JOHN DENEEN COLLINS (CFO and COO) has traded it 4 times. They made 0 purchases and 4 sales, selling 322,541 shares.
- JEFFREY FORD (Chief Accounting Officer) sold 21,935 shares.
- MONICA L. GREENBERG (EVP, Policy & General Counsel) has traded it 2 times. They made 0 purchases and 2 sales, selling 42,914 shares.
- ALEX KROMAN (EVP, Product and Technology) sold 120,047 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$LPSN Hedge Fund Activity
We have seen 26 institutional investors add shares of $LPSN stock to their portfolio, and 86 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SOLEL PARTNERS LP removed 4,094,659 shares (-100.0%) from their portfolio in Q3 2024
- DIVISADERO STREET CAPITAL MANAGEMENT, LP removed 2,266,971 shares (-100.0%) from their portfolio in Q2 2024
- VANGUARD GROUP INC removed 1,877,439 shares (-26.0%) from their portfolio in Q3 2024
- RENAISSANCE TECHNOLOGIES LLC added 1,601,400 shares (+1179.2%) to their portfolio in Q3 2024
- MACKENZIE FINANCIAL CORP removed 1,093,782 shares (-45.7%) from their portfolio in Q3 2024
- GOLDMAN SACHS GROUP INC removed 832,827 shares (-87.5%) from their portfolio in Q3 2024
- D. E. SHAW & CO., INC. removed 773,840 shares (-100.0%) from their portfolio in Q2 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
